LASILACTONE 50 MG TAB

1. All Details: Specifications
Dosage Form: Film-coated tablets.
Storage Conditions: Store in a cool dry place, protect from light.
Batch Number (B.No.): SP0862A.
Manufacturing Date (MFD.): MAR. 2025.
Expiry Date (EXP.): FEB. 2028.
Manufacturing License Number: Mfg. Lic. No.: G/25A/5283-A.
Maximum Retail Price (M.R.P.): Rs. 71.30 for 10 tablets (indicated as “MRP FOR 10 TABS. Rs.71.30 I.A.T.”, where I.A.T. stands for Inclusive of All Taxes).
Internal Material Identifiers: IN2260511j, [934810] GFL.
2. General
Brand: Lasilactone® 50.
Generic Name: Tablets of Frusemide and Spironolactone / Tablets of Furosemide and Spironolactone.
Quantity: 10 Tablets per strip (indicated by “FOR 10 TABS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the red statutory Schedule H prescription warning boxes).
Form Factor: Blister/strip packaging containing solid oral film-coated tablets.
Maximum Shelf Life: 2 years and 11 months (from March 2025 to February 2028).
Food Preference / FSSAI: Not Applicable. This is an allopathic, therapeutic therapeutic formulation intended for clinical treatment under strict medical supervision, not a commercial food product or dietary supplement. It falls entirely under national drug control frameworks instead of the FSSAI food authority, and it does not feature a vegetarian or non-vegetarian food preference icon.
3. Product Details: Ingredients
Each film-coated tablet contains:
Frusemide I.P.: 20 mg
Spironolactone I.P.: 50 mg
Excipients: q.s. (Quantity Sufficient)
Colours: Yellow Oxide of Iron & Titanium Dioxide
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Label:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Lasilactone® 50 is a widely utilized oral cardiovascular and renal prescription medication. It features a synergistic combination of two distinct diuretic agents: Frusemide (Furosemide), a potent loop diuretic that promotes the rapid excretion of water and sodium by inhibiting electrolyte reabsorption in the kidneys, and Spironolactone, a potassium-sparing diuretic that counteracts potassium loss by acting as an aldosterone antagonist. This dual mechanism is standardly prescribed under rigorous medical guidance to manage fluid retention (edema) caused by congestive heart failure, nephrotic syndrome, or liver cirrhosis, while maintaining a proper potassium balance in the blood.
Visual Presentation: The product comes in a textured silver aluminum foil strip designed to insulate the individual tablets from ambient humidity and light degradation. The layout incorporates a repeating blue linear branding pattern, stark dark typography for manufacturing metrics, twin distinct red safety blocks for prescription regulations, and the prominent corporate logo of Sanofi.
6. Manufacturer Information
Manufactured By: Sanofi India Limited.
Factory Location: Ankleshwar, Gujarat (partially visible under the license section).
7. Marketed By
Marketed by: Sanofi India Limited